Xylem affirms Q3 adjusted EPS and sales guidance ranges

Xylem (NYSE: XYL) affirms Q3 adjusted EPS guidance of $1.42-$1.47 versus a $1.46 analyst estimate and maintains Q3 sales outlook at $2.300 billion versus $2.316 billion expected.